Mersana Therapeutics, Inc. Shareholders' Equity
Mersana Therapeutics, Inc. had Shareholders' Equity of -$59.54 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-11-14
- 2025-09-30: Stockholders' Equity Attributable to Parent -$59.54M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$53.15M.
- 2025-03-31: Stockholders' Equity Attributable to Parent -$30.87M.
- 2024-12-31: Stockholders' Equity Attributable to Parent -$9.51M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-09-30 | -$59.54M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$53.15M 10-Q · filed 2025-11-14 | |
| 2025-03-31 | -$30.87M 10-Q · filed 2025-11-14 | |
| 2024-12-31 | -$9.51M 10-Q · filed 2025-11-14 | |
| 2024-09-30 | $1.05M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $8.43M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $27.98M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $36.90M 10-Q · filed 2025-11-14 | |
| 2023-09-30 | $52.20M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $89.80M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $64.29M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $92.06M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $90.23M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $134.03M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $140.53M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $121.74M 10-K · filed 2025-03-03 | |
| 2021-09-30 | $155.55M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $195.51M 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $197.94M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $228.09M 10-K · filed 2024-02-28 | |
| 2020-09-30 | $253.31M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $273.56M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $63.09M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $78.32M 10-K · filed 2023-02-28 | |
| 2019-09-30 | $93.05M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $108.51M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $124.07M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $8.79M 10-K · filed 2022-02-28 | |
| 2018-09-30 | $29.85M 10-Q · filed 2019-11-06 | $29.85M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $45.69M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $56.55M 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $69.99M 10-K · filed 2021-02-26 | |
| 2017-09-30 | $83.64M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$71.66M 10-Q · filed 2017-08-11 | |
| 2016-12-31 | -$55.62M 10-K · filed 2020-02-28 | |
| 2015-12-31 | -$42.69M 10-K · filed 2019-03-08 | |
| 2014-12-31 | -$26.61M 10-K · filed 2018-03-28 |